Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 3/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27959981 | 0.88 | CNR2 (0.36) | GAACNR2HSP90AA1HSP90AB1CNR1 | |
| SCHEMBL2911394 | 0.86 | CNR2 (0.40) | GAACNR2CNR1 | |
| SCHEMBL8016745 | 0.85 | CNR2 (0.41) | GAACNR2CNR1 | |
| SCHEMBL1535124 | 0.83 | MAPK1 (0.39) | GAAALDH1A1TSHRTDP1TAAR1 | |
| SCHEMBL2914748 | 0.77 | SHBG (0.38) | ALDH1A1TSHRTDP1TAAR1SMN1; SMN2 | |
| SCHEMBL815729 | 0.75 | TAAR1 (0.34) | ALDH1A1TSHRTDP1TAAR1 | |
| SCHEMBL18387167 | 0.75 | ACHE (0.34) | CYP2C19ALDH1A1TSHRTDP1 | |
| SCHEMBL19068294 | 0.75 | SLC6A2 (0.38) | ALDH1A1TDP1LMNAMAPK1 | |
| SCHEMBL19281833 | 0.75 | ALDH1A1 (0.31) | ALDH1A1TSHRTDP1TAAR1 | |
| SCHEMBL983814 | 0.75 | ALDH1A1 (0.56) | ALDH1A1TSHRTDP1CNR2HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2226328-B1 | PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND | ASAHI KASEI CHEMICALS CORP (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-8168812-B2 | Process for producing alkyl tin alkoxide compound and process for producing carbonic acid ester using said compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20100292496-A1 | Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-2226328-A1 | PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND | Asahi Kasei Chemicals Corporation (JP) | 2010-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292496-A1 | Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound | OXSR1, AOC2, OXER1 | GAA 4585/4885ALOX12 253/4885CYP2C19 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.